World's Best Scientists 2026 revealed!
Giampietro Corradin

Giampietro Corradin

D-Index & Metrics

Immunology

D-Index
71
Citations
16080
World Ranking
2344
National Ranking
61

Overview

Giampietro Corradin is affiliated with the University of Lausanne in Switzerland and has contributed extensively to the field of Medicine, with a primary focus on Public Health, Environmental and Occupational Health, Infectious Diseases, Immunology, Molecular Biology, and Radiology, Nuclear Medicine and Imaging. Their research encompasses topics related to Malaria Research and Control, Mosquito-borne diseases and control, SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research, COVID-19 Clinical Research Studies, vaccines and immunoinformatics approaches, as well as Invertebrate Immune Response Mechanisms.

Corradin's body of work includes the following recent papers:

  • Randomized clinical trial to assess the protective efficacy of a Plasmodium vivax CS synthetic vaccine, 2022, published in Nature Communications
  • Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens, 2020, published in Processes
  • Nanotechnological immunoassay for rapid label-free analysis of candidate malaria vaccines, 2020, published in Nanoscale
  • Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity, 2020, published in Frontiers in Immunology
  • Immunoreactivity of Sera From Low to Moderate Malaria-Endemic Areas Against Plasmodium vivax rPvs48/45 Proteins Produced in Escherichia coli and Chinese Hamster Ovary Systems, 2021, published in Frontiers in Immunology

Frequent co-authors collaborating with Corradin include:

  • Myriam Arévalo-Herrera
  • Sócrates Herrera
  • Andrey V. Kajava
  • Florian Μ. Wurm
  • Valentina Agnolon

Corradin's publications have appeared primarily in the following venues:

  • Frontiers in Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Processes
  • Nanoscale

The range of Corradin's research highlights involvement in clinical trials, vaccine design and evaluation, immunoassays, and protein production methods for infectious diseases such as malaria and viral pathogens. Their interdisciplinary approach integrates molecular biology, immunology, and public health strategies to address challenges in disease control and prevention.

Best Publications

  • Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells

    Paola Panina-Bordignon;Agnes Tan;Annemarie Termijtelen;Stefan Demotz

  • Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

    Pedro Romero;Janet L. Maryanski;Giampietro Corradin;Ruth S. Nussenzweig

  • Lymphocyte Specificity to Protein Antigens: I. Characterization of the Antigen-Induced in Vitro T Cell-Dependent Proliferative Response with Lymph Node Cells from Primed Mice

    Giampietro Corradin;Howard M. Etlinger;Jacques M. Chiller

  • Malarial hemozoin is a Nalp3 inflammasome activating danger signal.

    Catherine Dostert;Greta Guarda;Jackeline F. Romero;Philippe Menu

  • The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host

    Alida Coppi;Ramya Natarajan;Gabriele Pradel;Brandy L. Bennett

  • H—2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide

    Janet L. Maryanski;Pietro Pala;Giampietro Corradin;Bertrand R. Jordan

  • Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres : importance of polymer degradation and antigen release for immune response

    Claudio Thomasin;Giampietro Corradin;Ying Men;Hans P. Merkle

  • Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination.

    D Valmori;A Pessi;E Bianchi;G Corradin

  • A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide.

    Ying Men;Claudio Thomasin;Hans P. Merkle;Bruno Gander

  • A research agenda for malaria eradication: vaccines.

    S. Abdulla;P. Agre;P.L. Alonso;M. Arevalo-Herrera

  • A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein

    Joshua Tan;Joshua Tan;Brandon K Sack;David Oyen;Isabelle Zenklusen;Isabelle Zenklusen

  • Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen

    Régine Audran;Régine Audran;Michel Cachat;Floriana Lurati;Soe Soe

  • Update on the clinical development of candidate malaria vaccines

    W. Ripley Ballou;Myriam Arevalo-Herrera;Daniel Carucci;Thomas L. Richie

  • Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.

    Régine Audran;Katrin Peter;Jens Dannull;Ying Men

  • A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.

    Pierre Druilhe;François Spertini;Daw Soesoe;Giampietro Corradin

  • Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.

    Pål Johansen;Ying Men;Régine Audran;Giampietro Corradin

  • De novo design of fibrils made of short α-helical coiled coil peptides

    S.A Potekhin;T.N Melnik;V Popov;N.F Lanina

  • The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozoite repetitive epitope is I-Ab-restricted: possible implications for malaria vaccines.

    G Del Giudice;J A Cooper;J Merino;A S Verdini

  • MHC class I- and class II-restricted processing and presentation of microencapsulated antigens

    Ying Men;Régine Audran;Claudio Thomasin;Gérard Eberl

  • Delineation of several DR-restricted tetanus toxin T cell epitopes.

    Stephane Demotz;Antonio Lanzavecchia;Ulrich Eisel;Heiner Niemann

Frequent Co-Authors

François Spertini
François Spertini University Hospital of Lausanne
Myriam Arévalo-Herrera
Myriam Arévalo-Herrera Caucaseco Scientific Research Center
Elisabetta Bianchi
Elisabetta Bianchi Institut Pasteur
Andrey V. Kajava
Andrey V. Kajava University of Montpellier
Nicolas Fasel
Nicolas Fasel University of Lausanne
Pierre Druilhe
Pierre Druilhe Institut Pasteur
Ingrid Felger
Ingrid Felger University of Basel
Bruno Gander
Bruno Gander ETH Zurich
Gérard Eberl
Gérard Eberl Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare roles, many of which require specialized nursing qualifications. For those looking to advance within nursing, pursuing an acute care certification for FNP can be a valuable stepping stone, enabling practitioners to manage complex patient cases effectively.

Many students prefer accelerated programs to enter the workforce quickly. Options like accelerated FNP programs offer intensive training schedules tailored for those who already hold a nursing degree but want to advance rapidly.

Non-nurses interested in healthcare careers can explore foundational nursing education through online ADN programs for non nurses. These flexible programs focus on preparing students for essential nursing roles, laying a strong groundwork in clinical skills.

Additionally, for those seeking a quicker entry point into nursing, some of the easiest ABSN programs to get into provide a streamlined pathway to earning a Bachelor of Science in Nursing. These options help motivated learners transition smoothly into immunology-related healthcare careers.

Best Scientists Citing Giampietro Corradin

Trending Scientists

Recently Published Articles